Juul CEO Kevin Burns admitted his company doesn't know much about the long-term effects of vaping, and apologized to parents whose teens are addicted to the company's products, in an interview scheduled to air Monday on CNBC.
Why it matters: Teen vaping is being treated as a national epidemic, and there is little research about its long-term effects on users. Lawmakers are debating how to regulate vaping products, with some legislators pushing to raise the legal age to buy tobacco from 18 to 21 to curb teen use of e-cigarettes.
The Trump administration is looking for Congress to implement major changes to how the federal government pays for drugs, following a week of setbacks to its drug pricing agenda.
Yes, but: The major exception to this is the administration's proposal to tie what Medicare pays for some drugs to rates in other countries.
President Trump's decision to withdraw the rule that would've overhauled behind-the-scenes drug rebates led to huge stock gains yesterday for health insurance companies and pharmacy benefit managers, which have suffered since the rule was first proposed in January.
The big picture: The health care industry's largest middlemen dodged a giant bullet since rebates are an important part of their businesses. But they are not out of danger, as states and Congress are working to change how they influence the price of drugs.
